West Pharmaceutical Services Stock (NYSE:WST)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$330.92

52W Range

$206.80 - $336.82

50D Avg

$297.93

200D Avg

$269.58

Market Cap

$23.34B

Avg Vol (3M)

$857.97K

Beta

1.18

Div Yield

$0.87 (0.26%)

WST Company Profile


West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

10,600

IPO Date

Mar 17, 1980

Website

WST Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Proprietary Products$2.49B$2.33B$2.40B
Contract Manufactured Products$582.00M$558.70M$552.50M

Fiscal year ends in Dec 25 | Currency in USD

WST Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.07B$2.89B$2.95B
Operating Income$617.40M$594.60M$710.90M
Net Income$493.70M$492.70M$593.40M
EBITDA$723.60M$743.80M$844.10M
Basic EPS$6.83$6.75$7.99
Diluted EPS$6.80$6.69$7.88

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26Apr 23, 26 | 12:00 AM
Q4 25Feb 12, 26 | 12:00 AM
Q3 25Oct 23, 25 | 1:00 AM

Peer Comparison


TickerCompany
WATWaters Corporation
MEDPMedpace Holdings, Inc.
HOLXHologic, Inc.
COOThe Cooper Companies, Inc.
INCYIncyte Corporation
ZBHZimmer Biomet Holdings, Inc.
DGXQuest Diagnostics Incorporated
LHLabcorp Holdings Inc.
STESTERIS plc
ILMNIllumina, Inc.